- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04626453
Oxygenation Changes After 2-month Exercise in Sedentary Older Adults With Diabetes
September 20, 2021 updated by: Fei Zhao, State University of New York at Buffalo
Muscular and Cerebral Oxygenation Changes After Moderate-Intensity Exercise in Sedentary Older Adults With Type 2 Diabetes
The aim of the study is to determine the physiological evidence of how muscular and cerebral oxygenation changes link to fatigue, physical, and cognitive performance after moderate-intensity exercise in sedentary older adults with type 2 diabetes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is an experimental design.
One intervention group will do exercise for 2 months and be measured twice, at baseline, and after 2 months.
The other 2 control groups will be assessed just once without exercise intervention.
Our primary objective is to clarify physiological evidence of how muscular and cerebral oxygenation changes in sedentary older adults with diabetes after low-to-moderate intensity exercise.
The secondary objective is to determine fatigue, physical, cognitive performance changes, blood glucose level among sedentary older adults with diabetes after low-to-moderate intensity exercise.
Study Type
Interventional
Enrollment (Actual)
81
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14214
- University at Buffalo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
For the intervention group, the inclusion criteria are
- sedentary older adults 60 years or older who are living in their homes in the community
- diagnosed type 2 diabetes
- ambulatory with or without mobility devices such as a cane and/or walker
- Be able to follow simple exercise instructions without assistance.
For the comparison group, the inclusion criteria are
- individuals aged 60 years or older who are living in their homes, in the community;
- ambulatory with or without devices;
- able to follow simple exercise instructions without assistance
- able to walk six minutes as quickly as possible without any adverse symptoms including extreme pain on feet or joints, dizziness, vertigo, or nausea.
Exclusion Criteria:
For the intervention group, the exclusion criteria are
- foot deformities, cuts, blisters, or amputation, Achilles tendonitis, joint replacements within the past three months, Parkinson's disease, retinopathy such as severe glaucoma, current or uncontrolled vestibular disorders
- current smoking or smoking within the last 12 months
- current cardiopulmonary diseases, vascular disease, or stroke
- dementia indicating the inability to follow exercise instructions independently
- those who are currently or plan to receive physical therapy in the following three months
- individuals without English proficiency will be excluded
- If the individuals with blood glucose level are over 400 mg/dL or HbA1C > 8.0%, and
- type 1 diabetes.
For the comparison group, the exclusion criteria are
- individuals who have prediabetes, diabetes, or current cardiopulmonary diseases and stroke
- current smoking or smoking within the last 12 months
- individuals with foot deformities, cuts, blisters, or amputation, Achilles tendonitis, joint replacements within the past three months, Parkinson's disease, retinopathy such as severe glaucoma, current or uncontrolled vestibular disorders, and dementia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: sedentary older adults with Type 2 Diabetes
Sedentary older adults with Type 2 Diabetes as the intervention group will do a 2-month home exercise.
|
The 2-month exercise will be conducted at the participants' homes.
Participants will be recommended to perform the combined exercise, which consists of the resistance exercise and walking at a faster speed than leisure walking at a moderate-intensity, for 6 days/week.
They can decide which day they won't perform the exercise.
Participants will be encouraged to do progressive resistance exercise and walking twice a day, once in the morning and the other time in the afternoon.
Resistance exercise will be suggested to perform every other day for three days/week and walking as the aerobic exercise will be on alternate days for three days/week.
|
|
NO_INTERVENTION: Active older adults with Type 2 Diabetes
Active older adults with Type 2 Diabetes will not do exercise.
|
|
|
NO_INTERVENTION: Healthy older adults
Healthy older adults will not do exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
normalized ∆SmO2 rate
Time Frame: measure twice, at baseline and after 2 months
|
a parameter of muscular oxygenation to indicate the match or mismatch between oxygen supply and oxygen demand during the physical stimulus.
|
measure twice, at baseline and after 2 months
|
|
recovery time
Time Frame: measure twice, at baseline and after 2 months
|
a parameter of muscular oxygenation, time taken in seconds after the exercise to back to the beginning oxygenation level.
|
measure twice, at baseline and after 2 months
|
|
Resting SmO2
Time Frame: measure twice, at baseline and after 2 months
|
a parameter of muscular oxygenation, the average oxygenation level in % while sitting still for 3 minutes before doing physical performance tests.
|
measure twice, at baseline and after 2 months
|
|
Oxyhemoglobin differences
Time Frame: measure twice, at baseline and after 2 months
|
a parameter of cerebral oxygenation, the difference of the oxyhemoglobin in mL per gram before and after the cognitive tests.
|
measure twice, at baseline and after 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fatigue
Time Frame: measure twice, at baseline and after 2 months
|
Fatigue will be assessed by the Numeric Fatigue Scale (NFS) by selecting a number from 0 to 10. 0 is no fatigued at all, 10 is extremely fatigued.
|
measure twice, at baseline and after 2 months
|
|
Timed Up and Go test score in seconds
Time Frame: measure twice, at baseline and after 2 months
|
An assessment of physical performance.
Time in seconds from sitting up from a chair, walking to 3 meters, turning, walking back to sitting down on a chair.
|
measure twice, at baseline and after 2 months
|
|
Short Physical Performance Battery
Time Frame: measure twice, at baseline and after 2 months
|
An assessment of physical performance.
This test contains three sections: balance, walking speed and chair stand.
The scores are 0-12.
|
measure twice, at baseline and after 2 months
|
|
Bilateral Heel Raise test
Time Frame: measure twice, at baseline and after 2 months
|
An assessment of physical performance.
This test askes to do heel raise to the maximum height continuously.
Time to fatigued in seconds and the frequencies of heel raise are recorded.
|
measure twice, at baseline and after 2 months
|
|
6 Minute Walking Test
Time Frame: measure twice, at baseline and after 2 months
|
An assessment of physical performance.
The test assesses time in seconds when participants walk as fast as they can in 6 minutes.
|
measure twice, at baseline and after 2 months
|
|
Mini-cog test
Time Frame: measure twice, at baseline and after 2 months
|
An assessment of cognitive performance.
A Short term memory test.
|
measure twice, at baseline and after 2 months
|
|
Trail Making Test
Time Frame: measure twice, at baseline and after 2 months
|
An assessment of cognitive performance.
A executive function test.
|
measure twice, at baseline and after 2 months
|
|
blood glucose level in mg/dL
Time Frame: measure twice, at baseline and after 2 months
|
Blood glucose level before and after exercise
|
measure twice, at baseline and after 2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Fei Zhao, University at Buffalo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 29, 2020
Primary Completion (ACTUAL)
June 27, 2021
Study Completion (ACTUAL)
June 27, 2021
Study Registration Dates
First Submitted
October 30, 2020
First Submitted That Met QC Criteria
November 6, 2020
First Posted (ACTUAL)
November 12, 2020
Study Record Updates
Last Update Posted (ACTUAL)
September 21, 2021
Last Update Submitted That Met QC Criteria
September 20, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00004297
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
Clinical Trials on 2-month home moderate-intensity exercise
-
University of SharjahCompletedMultiple Sclerosis | Urinary IncontinenceJordan
-
University of UtahCompletedColorectal Neoplasms | Colorectal Cancer | Rectal Cancer | Rectal Neoplasms | Colonic Neoplasms | Colonic Cancer | Colorectal CarcinomaUnited States
-
Laboratoire des Adaptations Métaboliques à l'Exercice...CREPS Auvergne Rhône-Alpes / VichyCompletedOverweight | PostmenopausalFrance
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
Swinburne University of TechnologyNational Sports Institute of MalaysiaCompletedHealthy | Overweight | Physical InactivityMalaysia
-
Marquette UniversityRecruitingQuality of Life | Pain | Aging | Pain Management | Exercise Training | Aerobic Exercise | Sports | Athlete | Strength Training | Sports Medicine | Strength Training EffectsUnited States
-
University of Texas Southwestern Medical CenterAmerican Heart Association; Biotronik SE & Co. KG; American College of Sports...CompletedHypertrophic CardiomyopathyUnited States
-
Georgia State UniversityEmory UniversityWithdrawn
-
Yale UniversityNot yet recruitingObsessive-Compulsive Disorder (OCD)United States
-
HealthPartners InstituteRecruitingMyasthenia GravisUnited States